Abeprazan HCl (DWP14012; DWP-14012) hydrochlorideis a novel and potent potassium acid blocker or a potassium-competitive acid blocker, with the potential to be used as a potential alternative to proton pump inhibitor for the treatment of acid-related disease. Abeprazan hydrochloride inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required.

纯度：≥98%

CAS：1902954-87-3